IZN 6N-AV
Alternative Names: Centella-asiatica/Echinacea-purpurea/Sambucus-nigra; IZN 6N VS; IZN-6N-AVLatest Information Update: 16 Jul 2016
At a glance
- Originator Izun Pharma
- Class Anti-inflammatories; Herbal medicines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Vaginitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Vaginitis in Israel (Topical, Cream)
- 01 Dec 2014 Izun Pharmaceuticals initiates a phase I/II trial in Vaginitis in Israel (NCT02313545)
- 13 May 2013 Izun Pharmaceuticals plans a proof-of-concept trial for Vaginitis in Israel